nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—ESR1—schizophrenia	0.808	1	CbGaD
Trilostane—HSD3B1—gonad—schizophrenia	0.00952	0.115	CbGeAlD
Trilostane—HSD3B2—gonad—schizophrenia	0.00754	0.091	CbGeAlD
Trilostane—HSD3B1—endocrine gland—schizophrenia	0.00719	0.0868	CbGeAlD
Trilostane—HSD3B1—cerebellum—schizophrenia	0.00633	0.0765	CbGeAlD
Trilostane—HSD3B2—endocrine gland—schizophrenia	0.0057	0.0688	CbGeAlD
Trilostane—HSD3B2—nervous system—schizophrenia	0.00533	0.0644	CbGeAlD
Trilostane—HSD3B2—central nervous system—schizophrenia	0.00514	0.062	CbGeAlD
Trilostane—HSD3B2—brain—schizophrenia	0.00408	0.0492	CbGeAlD
Trilostane—ESR2—forebrain—schizophrenia	0.00321	0.0387	CbGeAlD
Trilostane—ESR2—telencephalon—schizophrenia	0.00295	0.0356	CbGeAlD
Trilostane—ESR2—gonad—schizophrenia	0.00246	0.0297	CbGeAlD
Trilostane—ESR1—forebrain—schizophrenia	0.0022	0.0265	CbGeAlD
Trilostane—ESR2—blood—schizophrenia	0.00214	0.0259	CbGeAlD
Trilostane—ESR1—telencephalon—schizophrenia	0.00202	0.0244	CbGeAlD
Trilostane—ESR2—endocrine gland—schizophrenia	0.00186	0.0224	CbGeAlD
Trilostane—ESR2—nervous system—schizophrenia	0.00174	0.021	CbGeAlD
Trilostane—ESR1—gonad—schizophrenia	0.00169	0.0203	CbGeAlD
Trilostane—ESR2—central nervous system—schizophrenia	0.00168	0.0202	CbGeAlD
Trilostane—ESR2—cerebellum—schizophrenia	0.00164	0.0198	CbGeAlD
Trilostane—ESR1—blood—schizophrenia	0.00147	0.0177	CbGeAlD
Trilostane—ESR2—brain—schizophrenia	0.00133	0.0161	CbGeAlD
Trilostane—ESR1—endocrine gland—schizophrenia	0.00127	0.0154	CbGeAlD
Trilostane—ESR1—nervous system—schizophrenia	0.00119	0.0144	CbGeAlD
Trilostane—ESR1—central nervous system—schizophrenia	0.00115	0.0139	CbGeAlD
Trilostane—ESR1—cerebellum—schizophrenia	0.00112	0.0135	CbGeAlD
Trilostane—ESR1—brain—schizophrenia	0.000911	0.011	CbGeAlD
Trilostane—Danazol—ESR1—schizophrenia	0.00074	0.215	CrCbGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.000573	0.00542	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ACSL6—schizophrenia	0.00057	0.00539	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC27A5—schizophrenia	0.00057	0.00539	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—S100B—schizophrenia	0.00057	0.00539	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—schizophrenia	0.000559	0.00529	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000557	0.00527	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—FOS—schizophrenia	0.000554	0.00524	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—ERBB4—schizophrenia	0.000545	0.00516	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—DAO—schizophrenia	0.000544	0.00515	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—MEF2C—schizophrenia	0.000544	0.00514	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—schizophrenia	0.000537	0.00508	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MPC2—schizophrenia	0.000522	0.00493	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PNP—schizophrenia	0.000522	0.00493	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00052	0.00492	CbGpPWpGaD
Trilostane—ESR1—Signaling events mediated by HDAC Class II—MEF2C—schizophrenia	0.000509	0.00482	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—NRG1—schizophrenia	0.000503	0.00476	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.000501	0.00474	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000486	0.0046	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLCH2—schizophrenia	0.000485	0.00459	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NDUFV2—schizophrenia	0.000485	0.00459	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.000484	0.00458	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.000484	0.00458	CbGpPWpGaD
Trilostane—Testosterone—MAOA—schizophrenia	0.000477	0.139	CrCbGaD
Trilostane—ESR1—ATF-2 transcription factor network—TH—schizophrenia	0.000473	0.00448	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.000471	0.00445	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDST3—schizophrenia	0.000456	0.00431	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIP4K2A—schizophrenia	0.000456	0.00431	CbGpPWpGaD
Trilostane—Estradiol—ESR1—schizophrenia	0.000452	0.132	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000452	0.00428	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—YWHAZ—schizophrenia	0.000446	0.00422	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR4A2—schizophrenia	0.000445	0.00421	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ACSL6—schizophrenia	0.000432	0.00409	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC27A5—schizophrenia	0.000432	0.00409	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TH—schizophrenia	0.000431	0.00408	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000422	0.004	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—AKT1—schizophrenia	0.000422	0.00399	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TH—schizophrenia	0.000413	0.0039	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP26B1—schizophrenia	0.000412	0.0039	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—DAO—schizophrenia	0.000412	0.0039	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PRL—schizophrenia	0.000412	0.00389	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.000406	0.00384	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PNP—schizophrenia	0.000395	0.00374	CbGpPWpGaD
Trilostane—Progesterone—ESR1—schizophrenia	0.000384	0.112	CrCbGaD
Trilostane—ESR2—Gene Expression—TSNAX—schizophrenia	0.000373	0.00353	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDUFV2—schizophrenia	0.000368	0.00348	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TPH1—schizophrenia	0.000368	0.00348	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GCLM—schizophrenia	0.000368	0.00348	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.000364	0.00344	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRG3—schizophrenia	0.000358	0.00338	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GFAP—schizophrenia	0.000354	0.00334	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.000351	0.00332	CbGpPWpGaD
Trilostane—Estradiol—CYP1A2—schizophrenia	0.000349	0.101	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000347	0.00328	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIP4K2A—schizophrenia	0.000346	0.00327	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PRKD1—schizophrenia	0.000346	0.00327	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000343	0.00324	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—FOS—schizophrenia	0.000342	0.00323	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—GSK3B—schizophrenia	0.000338	0.0032	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL10—schizophrenia	0.000335	0.00317	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—FOS—schizophrenia	0.00033	0.00312	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000326	0.00309	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL10—schizophrenia	0.000321	0.00304	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—EP300—schizophrenia	0.000321	0.00303	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—AKT1—schizophrenia	0.00032	0.00302	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.000315	0.00298	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP26B1—schizophrenia	0.000313	0.00296	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—LSM1—schizophrenia	0.000304	0.00288	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.000299	0.00283	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.000297	0.00281	CbGpPWpGaD
Trilostane—Progesterone—CYP1A2—schizophrenia	0.000296	0.0861	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.000294	0.00278	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GAPDH—schizophrenia	0.000288	0.00273	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CLOCK—schizophrenia	0.000286	0.0027	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.000286	0.0027	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.000285	0.0027	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000285	0.0027	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000282	0.00267	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TPH2—schizophrenia	0.000279	0.00263	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GCLM—schizophrenia	0.000279	0.00263	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPH1—schizophrenia	0.000279	0.00263	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CACNB2—schizophrenia	0.000279	0.00263	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.000278	0.00263	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—schizophrenia	0.000277	0.00262	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—DPYD—schizophrenia	0.000274	0.00259	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000263	0.00248	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PRKD1—schizophrenia	0.000262	0.00248	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—FOS—schizophrenia	0.000261	0.00246	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CACNA1C—schizophrenia	0.000255	0.00241	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3C2A—schizophrenia	0.000248	0.00235	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—FOS—schizophrenia	0.000233	0.0022	CbGpPWpGaD
Trilostane—Progesterone—CYP2D6—schizophrenia	0.000228	0.0665	CrCbGaD
Trilostane—ESR2—Generic Transcription Pathway—NOTCH4—schizophrenia	0.000228	0.00216	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—FOS—schizophrenia	0.000227	0.00215	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—EP300—schizophrenia	0.000227	0.00214	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR4A2—schizophrenia	0.000224	0.00212	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.000224	0.00212	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SNAP25—schizophrenia	0.000223	0.00211	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP2D6—schizophrenia	0.000223	0.00211	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—schizophrenia	0.000222	0.0021	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GAPDH—schizophrenia	0.000219	0.00207	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—EP300—schizophrenia	0.000218	0.00206	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CLOCK—schizophrenia	0.000217	0.00205	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—GSK3B—schizophrenia	0.000216	0.00205	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000216	0.00204	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR4A2—schizophrenia	0.000214	0.00203	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000214	0.00202	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPH2—schizophrenia	0.000211	0.002	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CACNB2—schizophrenia	0.000211	0.002	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EP300—schizophrenia	0.000211	0.00199	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—DPYD—schizophrenia	0.000208	0.00196	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PRL—schizophrenia	0.000206	0.00195	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.000202	0.00191	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP1A2—schizophrenia	0.000201	0.0019	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TH—schizophrenia	0.000198	0.00188	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SMG6—schizophrenia	0.000196	0.00185	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CACNA1C—schizophrenia	0.000193	0.00183	CbGpPWpGaD
Trilostane—Estradiol—ABCB1—schizophrenia	0.000192	0.0559	CrCbGaD
Trilostane—ESR1—Signaling by ERBB4—S100B—schizophrenia	0.000192	0.00182	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TSNAX—schizophrenia	0.000188	0.00178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3C2A—schizophrenia	0.000188	0.00178	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—schizophrenia	0.000188	0.00177	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB4—schizophrenia	0.000184	0.00174	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.000176	0.00166	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—EP300—schizophrenia	0.000173	0.00163	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—schizophrenia	0.000171	0.00162	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRG1—schizophrenia	0.000169	0.0016	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP2D6—schizophrenia	0.000169	0.0016	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—COMT—schizophrenia	0.000169	0.0016	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SNAP25—schizophrenia	0.000169	0.0016	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTP1—schizophrenia	0.000168	0.00159	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MAOA—schizophrenia	0.000168	0.00158	CbGpPWpGaD
Trilostane—Progesterone—ABCB1—schizophrenia	0.000163	0.0475	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000163	0.00154	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—EP300—schizophrenia	0.000162	0.00153	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—schizophrenia	0.000159	0.00151	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—schizophrenia	0.000159	0.0015	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ABCB1—schizophrenia	0.000159	0.0015	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB3—schizophrenia	0.000159	0.0015	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—EP300—schizophrenia	0.000157	0.00149	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PLA2G4A—schizophrenia	0.000154	0.00146	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GSTM1—schizophrenia	0.000154	0.00146	CbGpPWpGaD
Trilostane—Testosterone—ABCB1—schizophrenia	0.000154	0.0449	CrCbGaD
Trilostane—ESR1—Gene Expression—LSM1—schizophrenia	0.000153	0.00145	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP1A2—schizophrenia	0.000153	0.00144	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.000151	0.00142	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—EP300—schizophrenia	0.000151	0.00142	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TH—schizophrenia	0.00015	0.00142	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.000148	0.0014	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.000144	0.00136	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—schizophrenia	0.00014	0.00132	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—schizophrenia	0.000136	0.00129	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.000134	0.00127	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.000134	0.00126	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—COMT—schizophrenia	0.000128	0.00121	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000128	0.00121	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTP1—schizophrenia	0.000127	0.0012	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MAOA—schizophrenia	0.000127	0.0012	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—schizophrenia	0.000127	0.0012	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOA1—schizophrenia	0.000126	0.00119	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000123	0.00116	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GSK3B—schizophrenia	0.000123	0.00116	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCB1—schizophrenia	0.00012	0.00114	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLA2G4A—schizophrenia	0.000117	0.00111	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GSTM1—schizophrenia	0.000117	0.00111	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NOTCH4—schizophrenia	0.000115	0.00109	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—schizophrenia	0.000111	0.00105	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NOTCH4—schizophrenia	0.00011	0.00104	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.000109	0.00103	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR4A2—schizophrenia	0.000108	0.00102	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—schizophrenia	0.000108	0.00102	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—schizophrenia	0.000103	0.000978	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SMG6—schizophrenia	9.89e-05	0.000935	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—DNMT1—schizophrenia	9.84e-05	0.000931	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—HSPA8—schizophrenia	9.7e-05	0.000918	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—schizophrenia	9.62e-05	0.00091	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	9.57e-05	0.000905	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOA1—schizophrenia	9.51e-05	0.0009	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—schizophrenia	9.31e-05	0.000881	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—HSPA1A—schizophrenia	8.84e-05	0.000836	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—schizophrenia	8.61e-05	0.000814	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DGKI—schizophrenia	8.26e-05	0.000782	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EP300—schizophrenia	8.14e-05	0.00077	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	8.09e-05	0.000766	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	8.08e-05	0.000764	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP1R1B—schizophrenia	7.56e-05	0.000715	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—EP300—schizophrenia	7.24e-05	0.000684	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FZD3—schizophrenia	7.03e-05	0.000665	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	6.74e-05	0.000638	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GRM2—schizophrenia	6.61e-05	0.000625	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TAAR6—schizophrenia	6.61e-05	0.000625	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FES—schizophrenia	6.61e-05	0.000625	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP3CC—schizophrenia	6.61e-05	0.000625	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—YWHAZ—schizophrenia	6.41e-05	0.000607	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NGEF—schizophrenia	6.11e-05	0.000578	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTS—schizophrenia	5.98e-05	0.000565	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—schizophrenia	5.82e-05	0.000551	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RTN4—schizophrenia	5.62e-05	0.000531	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GRM3—schizophrenia	5.62e-05	0.000531	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RGS4—schizophrenia	5.62e-05	0.000531	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NOTCH4—schizophrenia	5.53e-05	0.000523	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR6—schizophrenia	5.51e-05	0.000522	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—EP300—schizophrenia	5.48e-05	0.000519	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	5.47e-05	0.000518	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—schizophrenia	5.36e-05	0.000507	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAG—schizophrenia	5.33e-05	0.000504	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—DNMT1—schizophrenia	4.96e-05	0.000469	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	4.92e-05	0.000465	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—HSPA8—schizophrenia	4.89e-05	0.000463	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—schizophrenia	4.89e-05	0.000463	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CHRM1—schizophrenia	4.87e-05	0.000461	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	4.83e-05	0.000456	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL3RA—schizophrenia	4.75e-05	0.000449	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TLE1—schizophrenia	4.63e-05	0.000438	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRG3—schizophrenia	4.63e-05	0.000438	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GFAP—schizophrenia	4.58e-05	0.000433	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GRM5—schizophrenia	4.53e-05	0.000428	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—HSPA1A—schizophrenia	4.46e-05	0.000421	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TLE3—schizophrenia	4.39e-05	0.000415	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—schizophrenia	4.37e-05	0.000414	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCK—schizophrenia	4.14e-05	0.000392	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	4.08e-05	0.000385	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PDE4B—schizophrenia	4.04e-05	0.000382	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCKAR—schizophrenia	3.97e-05	0.000376	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADORA2A—schizophrenia	3.85e-05	0.000364	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FGA—schizophrenia	3.69e-05	0.000349	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPY—schizophrenia	3.6e-05	0.00034	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOTCH4—schizophrenia	3.6e-05	0.00034	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ATP2A2—schizophrenia	3.6e-05	0.00034	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—OXT—schizophrenia	3.47e-05	0.000328	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR1B—schizophrenia	3.47e-05	0.000328	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR1A—schizophrenia	3.34e-05	0.000316	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—schizophrenia	3.31e-05	0.000313	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPS—schizophrenia	3.29e-05	0.000311	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—YWHAZ—schizophrenia	3.23e-05	0.000306	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2C—schizophrenia	3.23e-05	0.000305	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD1—schizophrenia	3.23e-05	0.000305	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK2—schizophrenia	3.14e-05	0.000297	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD3—schizophrenia	3.12e-05	0.000296	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD4—schizophrenia	3.03e-05	0.000287	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CNR1—schizophrenia	2.9e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DRD2—schizophrenia	2.83e-05	0.000267	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR7—schizophrenia	2.83e-05	0.000267	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRL—schizophrenia	2.67e-05	0.000252	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—S100B—schizophrenia	2.49e-05	0.000235	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB4—schizophrenia	2.38e-05	0.000225	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLA2G4A—schizophrenia	2.24e-05	0.000212	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRG1—schizophrenia	2.2e-05	0.000208	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MEF2C—schizophrenia	2.18e-05	0.000206	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—YWHAZ—schizophrenia	2.1e-05	0.000199	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB3—schizophrenia	2.06e-05	0.000195	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2A—schizophrenia	1.98e-05	0.000187	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—schizophrenia	1.93e-05	0.000183	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—schizophrenia	1.84e-05	0.000174	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOA1—schizophrenia	1.82e-05	0.000172	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GSK3B—schizophrenia	1.59e-05	0.000151	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EP300—schizophrenia	1.05e-05	9.92e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—schizophrenia	9.75e-06	9.22e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—schizophrenia	7.5e-06	7.1e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—schizophrenia	6.34e-06	5.99e-05	CbGpPWpGaD
